Document is current
Any future updates will be listed below
-
Authors
Ortiz, Guillermo A.
Garcia-Tsao, Guadalupe
-
Funding
Funding for this research was provided by:
National Institutes of Health
- License Information
-
More Information
Article History
First Online: 19 February 2019
Compliance with Ethical Standards
:
: Guadalupe Garcia-Tsao participated in and is the first author of the open-label study on the effect of emricasan on hepatic venous pressure gradient (sponsored by Conatus). Guadalupe Garcia-Tsao reports personal fees from Conatus, grants and personal fees from Intercept, personal fees from Abbvie, personal fees from Biovie, personal fees from Enterome, personal fees from Grifols, personal fees from Galectin, outside the submitted work. Guillermo Ortiz declares no potential conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
